Leica Microsystems has announced an agreement to acquire Surgipath Medical Industries Inc.
Surgipath, Richmond, Ill, is a provider of consumables and medical device accessories for clinical histology and research laboratories. Surgipath’s range of products includes processing reagents, storage and specimen transport devices, cytology accessories and safety products. These products will serve to complement and expand Leica Microsystems’ broad histology product range.
John Monek, CEO of Surgipath, said, “the amalgamation of the product lines of both companies gives the industry a comprehensive partner for all histology requirements. Leveraging the strengths of both organizations will create further opportunity for the creation of innovative, high-quality solutions. That makes this acquisition an exciting prospect for both customers and employees worldwide.”
Similarly, Anne De Greef-Safft, President of Leica Microsystems’ Biosystems Division, said “this acquisition is another significant step towards enabling the pathologist to achieve a more reliable diagnosis. We are delighted to add Surgipath to our solutions portfolio.”
Leica Microsystems is a global designer and producer of innovative, high-tech, precision optical systems for the analysis of microstructures as well as a broad product portfolio for histopathology.